msadmin
Doudna Lab uses AI to design novel gene-editing enzymes from scratch
Nobel laureate Jennifer Doudna's team uses inverse protein folding AI to create never-before-seen genome editing enzymes.
CHAI recruits 2,000 health workers for public health genAI push
The Coalition for Health AI launches a national initiative with enterprise AI licenses donated by OpenAI and Anthropic.
AI-powered biosimulation shakes up animal testing in drug development
Nature Biotechnology reports that FDA's push to reduce animal testing has fueled a boom in AI biosimulation and digital twin…
Big tech launches consumer health AI assistants as accuracy questions grow
OpenAI, Google, Amazon, Microsoft and Anthropic have all launched consumer-facing AI health tools in 2026.
Chai Discovery raises $400 million Series C for AI drug design
The startup behind AI molecule models used by Lilly, Novartis and Pfizer hits a $3.8 billion valuation.
Insilico and SK Biopharm ink $2.5 billion AI drug discovery deal
The partnership targets neuroimmune and CNS disorders using Insilico's Pharma.AI engine, with $18 million in upfront payments and milestone-based upside.
Drug metabolism AI contest shows data matters more than model size
Inductive Bio won the openADMET competition, but a 28-way statistical tie suggests data quality may trump model architecture for predicting…
Insilico and Bora Pharma bring generative AI to drug manufacturing
The alliance extends Insilico's PandaOmics and Chemistry42 platforms into pharmaceutical manufacturing for the first time, targeting a $168B CDMO industry.